Sanofi isn’t saying how much it is paying for the OTC rights to Tamiflu in the US, but explained that a successful switch would “support our global cough and cold strategy by expanding into ...

Sanofi had rights to the OTC version of the drug that was recalled ... Some voluntarily took their products off the market as soon as the NDMA finding was reported by the FDA.

OTC Consumer Health Market Growth 2025 BURLINGAME, CA, UNITED STATES, March 11, 2025 /EINPresswire / --The Global OTC Consumer Health ...

Sanofi (NASDAQ:SNY) is reportedly lining up banks for a potential spinoff of its consumer health products division.The French drugmaker has asked banks to submit proposals to work on the deal ...

In 2014, Sanofi (NASDAQ:SNY) reached an agreement with Eli Lilly (NYSE:LLY) to buy exclusive rights to seek regulatory approval for Cialis OTC in countries including the U.S. when certain LLY ...

Sanofi is one of the biggest players in the Allergy category globally. But in the UK its portfolio was still underrepresented. Aware of a high level of dissatisfaction from UK allergy sufferers with ...